-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Pharmaceutical Network Market Analysis: Recently, Hengrui Pharmaceuticals disclosed its 2019 annual report Data show that the company achieved operating income of 23.289 billion yuan in 2019, and net profit of 5.328 billion yuan, up 33.7% and 31.05 percent year-on-year, respectively Its revenue and home-to-home net profit growth accelerated compared with previous years However, it is worth noting that Hengrui Pharma also faces the potential risk of a significant slowdown in revenue growth in the fourth quarter of 2019 and a downward trend in the overall cash content of net profit in the last five years What should pharmaceutical companies do when performance growth slows?
In fact, in recent years, the reform of the national medical system has been further deepened, and the implementation of policies such as medical insurance control fees, secondary bargaining, total volume control, key monitoring catalogues, and 4 plus 7 band volume procurement has ushered in many challenges in the pharmaceutical industry, which has also led to a slowdown in the performance growth rate of many pharmaceutical companies Data show that of the 89 listed companies that have published their 2019 results, 68 have reported a slower growth rate in 2019 than the previous year
In this regard, the industry said, in this round due to the policy caused by the pharmaceutical company shuffle process, how to control the production costs of products, improve profitability, will become the future survival and development of pharmaceutical companies key
Generally speaking, to control the production cost of a product, you usually have to consider the cost of materials, labor costs, power costs and manufacturing costs At present, pharmaceutical companies are struggling to reduce the cost of each link to improve profitability It is understood that many enterprises are upgrading the cost management system For example, in the case of consistency evaluation of generic product syllability and quality requirements, many API enterprises began to consider raw materialself supply and large-scale production, and thus achieve self-sufficiency, effective cost control
Some companies are introducing more automated, environmentally friendly equipment or production lines to reduce labor costs, environmental costs The industry said that in the continuous development of technology, the introduction of automated production lines for pharmaceutical companies have an important significance, it can help pharmaceutical companies to achieve continuous production, improve production efficiency and competitiveness, and further reduce production costs
At present, in addition to pharmaceutical companies actively adopt various ways to "self-help", as a pharmaceutical industry closely related to pharmaceutical equipment enterprises, also began to actively help pharmaceutical companies "reduce the burden." Many pharmaceutical companies say that the current drug companies in the cost control problem encountered a major challenge is how to further save energy Therefore, many companies represented by leading enterprises in various sub-sectors of the pharmaceutical equipment sector are moving towards automation, intelligence, digitalization, to produce some highly automated, intelligent equipment devices, and to create a "unmanned production" model to robot production machines, reduce the high cost, high error rate, high risk, to help the pharmaceutical industry high-quality development, to achieve full information traceability
In addition, the author also learned that there are many pharmaceutical equipment enterprises, is by improving the equipment energy conservation and environmental protection capacity, service quality level, etc , to try to provide help for pharmaceutical companies to control costs
In general, want to control the production costs of products, so that sustainable development of enterprises, not as long as a good way can be achieved, in addition to the above-mentioned measures, by improving product profitability, carry out full excavation, resource conservation, strengthen management and other aspects of cooperation, in order to enable pharmaceutical companies in the future to win more opportunities for development.